View in EDS HTML Full Text PDF Full Text

Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy.

Saved in:
Bibliographic Details
Title: Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy.
Authors: Roberti, Roberta1 (AUTHOR), Politi, Cristina1,2 (AUTHOR), Anzellotti, Francesca3 (AUTHOR), Belcastro, Vincenzo4 (AUTHOR), Beretta, Simone5 (AUTHOR), Boero, Giovanni6 (AUTHOR), Bonanni, Paolo7 (AUTHOR), Canafoglia, Laura8 (AUTHOR), D'Aniello, Alfredo9 (AUTHOR), Dainese, Filippo10 (AUTHOR), De Caro, Carmen1,11 (AUTHOR), Di Gennaro, Giancarlo9 (AUTHOR), Di Giacomo, Roberta12 (AUTHOR), DiFrancesco, Jacopo C.5 (AUTHOR), Dono, Fedele3,13 (AUTHOR), Falcicchio, Giovanni14 (AUTHOR), Ferlazzo, Edoardo15,16 (AUTHOR), Foschi, Nicoletta17 (AUTHOR), Gambardella, Antonio18 (AUTHOR), Giordano, Alfonso19 (AUTHOR)
Source: Neurology & Therapy. Feb2026, Vol. 15 Issue 1, p213-235. 23p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938253
DOI:10.1007/s40120-025-00860-5